cognitive cybersecurity intelligence

News and Analysis


Novel software measures the significance of specific genomic biomarkers to help predict diseases

IntelliGenes, a new software at Rutgers Health, uses artificial intelligence and machine learning to measure the significance of genomic biomarkers, potentially predicting diseases. The software, which merges traditional statistical methods with state-of-the-art algorithms, is intuitive enough for non-experts to use. In a study, IntelliGenes was used to discover novel biomarkers and accurately predict cardiovascular disease.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts